# Weyco Group Inc: financial statements, quarterly

WEYS · Nasdaq · CIK 106532 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/weys.md) · [Financials](/companies/weys/financials.md) · [Filings](/companies/weys/filings.md) · [Insiders](/companies/weys/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/weys/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [84.2](/filings/0001558370-24-015014.md) | [80.6 d](/filings/0001558370-25-002984.md) | [71.6](/filings/0001558370-25-007097.md) | [63.9](/filings/0001558370-25-010741.md) | [74.3](/filings/0001104659-25-108344.md) | [80.5 d](/filings/0001104659-26-027690.md) | [68.0](/filings/0001104659-26-057266.md) | [58.2](/filings/0001104659-26-092615.md) | [73.1](/filings/0001104659-25-108344.md) | [76.8 d](/filings/0001104659-26-027690.md) | [68.0](/filings/0001104659-26-057266.md) | [62.2](/filings/0001104659-26-092615.md) |
| Cost of revenue | $m | [48.0](/filings/0001558370-24-015014.md) | [40.0 d](/filings/0001558370-25-002984.md) | [39.6](/filings/0001558370-25-007097.md) | [35.8](/filings/0001558370-25-010741.md) | [41.4](/filings/0001104659-25-108344.md) | [41.9 d](/filings/0001104659-26-027690.md) | [37.7](/filings/0001104659-26-057266.md) | [33.0](/filings/0001104659-26-092615.md) | [43.3](/filings/0001104659-25-108344.md) | [43.0 d](/filings/0001104659-26-027690.md) | [37.9](/filings/0001104659-26-057266.md) | [18.4](/filings/0001104659-26-092615.md) |
| Gross profit | $m | [36.2](/filings/0001558370-24-015014.md) | [40.6 d](/filings/0001558370-25-002984.md) | [32.0](/filings/0001558370-25-007097.md) | [28.1](/filings/0001558370-25-010741.md) | [32.9](/filings/0001104659-25-108344.md) | [38.5 d](/filings/0001104659-26-027690.md) | [30.4](/filings/0001104659-26-057266.md) | [25.2](/filings/0001104659-26-092615.md) | [29.8](/filings/0001104659-25-108344.md) | [33.8 d](/filings/0001104659-26-027690.md) | [30.1](/filings/0001104659-26-057266.md) | [43.8](/filings/0001104659-26-092615.md) |
| Selling, general and administrative | $m | [23.7](/filings/0001558370-24-015014.md) | [29.1 d](/filings/0001558370-25-002984.md) | [23.8](/filings/0001558370-25-007097.md) | [21.4](/filings/0001558370-25-010741.md) | [22.7](/filings/0001104659-25-108344.md) | [27.0 d](/filings/0001104659-26-027690.md) | [23.3](/filings/0001104659-26-057266.md) | [21.3](/filings/0001104659-26-092615.md) | [21.7](/filings/0001104659-25-108344.md) | [23.6 d](/filings/0001104659-26-027690.md) | [22.6](/filings/0001104659-26-057266.md) | [26.8](/filings/0001104659-26-092615.md) |
| Operating income | $m | [12.4](/filings/0001558370-24-015014.md) | [11.5 d](/filings/0001558370-25-002984.md) | [8.3](/filings/0001558370-25-007097.md) | [6.7](/filings/0001558370-25-010741.md) | [10.2](/filings/0001104659-25-108344.md) | [11.5 d](/filings/0001104659-26-027690.md) | [7.0](/filings/0001104659-26-057266.md) | [3.9](/filings/0001104659-26-092615.md) | [8.1](/filings/0001104659-25-108344.md) | [10.2 d](/filings/0001104659-26-027690.md) | [7.5](/filings/0001104659-26-057266.md) | [17.0](/filings/0001104659-26-092615.md) |
| Interest expense | $m | [0.0](/filings/0001410578-23-002272.md) | [0.0 d](/filings/0001558370-24-003196.md) | not reported | not reported | [0.0](/filings/0001104659-25-108344.md) | [0.0 d](/filings/0001104659-26-027690.md) | [0.0](/filings/0001104659-26-057266.md) | [0.0](/filings/0001104659-26-092615.md) | [0.0 d](/filings/0001104659-25-108344.md) | [0.0 d](/filings/0001104659-26-027690.md) | [0.0](/filings/0001104659-26-057266.md) | [0.0 d](/filings/0001104659-26-092615.md) |
| Income tax | $m | [3.2](/filings/0001558370-24-015014.md) | [3.2 d](/filings/0001558370-25-002984.md) | [2.4](/filings/0001558370-25-007097.md) | [1.9](/filings/0001558370-25-010741.md) | [2.8](/filings/0001104659-25-108344.md) | [2.4 d](/filings/0001104659-26-027690.md) | [2.0](/filings/0001104659-26-057266.md) | [2.4](/filings/0001104659-26-092615.md) | [2.4](/filings/0001104659-25-108344.md) | [2.2 d](/filings/0001104659-26-027690.md) | [2.2](/filings/0001104659-26-057266.md) | [5.3](/filings/0001104659-26-092615.md) |
| Net income | $m | [9.3](/filings/0001558370-24-015014.md) | [8.5 d](/filings/0001558370-25-002984.md) | [6.7](/filings/0001558370-25-007097.md) | [5.6](/filings/0001558370-25-010741.md) | [8.1](/filings/0001104659-25-108344.md) | [10.0 d](/filings/0001104659-26-027690.md) | [5.5](/filings/0001104659-26-057266.md) | [2.3](/filings/0001104659-26-092615.md) | [6.6](/filings/0001104659-25-108344.md) | [8.7 d](/filings/0001104659-26-027690.md) | [6.1](/filings/0001104659-26-057266.md) | [13.3](/filings/0001104659-26-092615.md) |
| Diluted EPS | $ per share | [0.98](/filings/0001558370-24-015014.md) | not reported | [0.69](/filings/0001558370-25-007097.md) | [0.59](/filings/0001558370-25-010741.md) | [0.84](/filings/0001104659-25-108344.md) | not reported | [0.57](/filings/0001104659-26-057266.md) | [0.24](/filings/0001104659-26-092615.md) | [0.69](/filings/0001104659-25-108344.md) | not reported | [0.64](/filings/0001104659-26-057266.md) | [1.39](/filings/0001104659-26-092615.md) |
| Basic EPS | $ per share | [0.99](/filings/0001558370-24-015014.md) | not reported | [0.70](/filings/0001558370-25-007097.md) | [0.60](/filings/0001558370-25-010741.md) | [0.85](/filings/0001104659-25-108344.md) | not reported | [0.58](/filings/0001104659-26-057266.md) | [0.24](/filings/0001104659-26-092615.md) | [0.70](/filings/0001104659-25-108344.md) | not reported | [0.65](/filings/0001104659-26-057266.md) | [1.41](/filings/0001104659-26-092615.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [33.4](/filings/0001410578-23-002272.md) | [69.3](/filings/0001558370-25-002984.md) | [78.3](/filings/0001558370-24-007553.md) | [78.4](/filings/0001558370-24-011519.md) | [75.5](/filings/0001558370-24-015014.md) | [71.0](/filings/0001104659-26-027690.md) | [71.5](/filings/0001558370-25-007097.md) | [77.4](/filings/0001558370-25-010741.md) | [72.9](/filings/0001104659-25-108344.md) | [96.0](/filings/0001104659-26-092615.md) | [89.0](/filings/0001104659-26-057266.md) | [93.7](/filings/0001104659-26-092615.md) |
| Current assets | $m | [171](/filings/0001410578-23-002272.md) | [190](/filings/0001558370-25-002984.md) | [186](/filings/0001558370-24-007553.md) | [188](/filings/0001558370-24-011519.md) | [198](/filings/0001558370-24-015014.md) | [209](/filings/0001104659-26-027690.md) | [184](/filings/0001558370-25-007097.md) | [186](/filings/0001558370-25-010741.md) | [191](/filings/0001104659-25-108344.md) | [205](/filings/0001104659-26-092615.md) | [183](/filings/0001104659-26-057266.md) | [199](/filings/0001104659-26-092615.md) |
| Total assets | $m | [289](/filings/0001410578-23-002272.md) | [309](/filings/0001558370-25-002984.md) | [303](/filings/0001558370-24-007553.md) | [304](/filings/0001558370-24-011519.md) | [315](/filings/0001558370-24-015014.md) | [324](/filings/0001104659-26-027690.md) | [299](/filings/0001558370-25-007097.md) | [301](/filings/0001558370-25-010741.md) | [304](/filings/0001104659-25-108344.md) | [320](/filings/0001104659-26-092615.md) | [296](/filings/0001104659-26-057266.md) | [311](/filings/0001104659-26-092615.md) |
| Current liabilities | $m | [20.1](/filings/0001410578-23-002272.md) | [29.6](/filings/0001558370-25-002984.md) | [21.1](/filings/0001558370-24-007553.md) | [19.0](/filings/0001558370-24-011519.md) | [23.0](/filings/0001558370-24-015014.md) | [47.3](/filings/0001104659-26-027690.md) | [19.1](/filings/0001558370-25-007097.md) | [20.9](/filings/0001558370-25-010741.md) | [21.2](/filings/0001104659-25-108344.md) | [48.6](/filings/0001104659-26-092615.md) | [22.2](/filings/0001104659-26-057266.md) | [26.4](/filings/0001104659-26-092615.md) |
| Total liabilities | $m | [53.5](/filings/0001410578-23-002272.md) | [64.8](/filings/0001558370-25-002984.md) | [55.2](/filings/0001558370-24-007553.md) | [52.6](/filings/0001558370-24-011519.md) | [56.6](/filings/0001558370-24-015014.md) | [78.5](/filings/0001104659-26-027690.md) | [50.7](/filings/0001558370-25-007097.md) | [52.9](/filings/0001558370-25-010741.md) | [52.7](/filings/0001104659-25-108344.md) | [80.1](/filings/0001104659-26-092615.md) | [52.6](/filings/0001104659-26-057266.md) | [56.3](/filings/0001104659-26-092615.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [235](/filings/0001410578-23-002272.md) | [244](/filings/0001558370-25-002984.md) | [248](/filings/0001558370-24-007553.md) | [251](/filings/0001558370-24-011519.md) | [258](/filings/0001558370-24-015014.md) | [246](/filings/0001104659-26-027690.md) | [249](/filings/0001558370-25-007097.md) | [248](/filings/0001558370-25-010741.md) | [251](/filings/0001104659-25-108344.md) | [240](/filings/0001104659-26-092615.md) | [244](/filings/0001104659-26-057266.md) | [255](/filings/0001104659-26-092615.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.4 d](/filings/0001558370-24-015014.md) | [35.7 d](/filings/0001558370-25-002984.md) | [14.3](/filings/0001558370-25-007097.md) | [3.3 d](/filings/0001558370-25-010741.md) | [(0.4) d](/filings/0001104659-25-108344.md) | [20.4 d](/filings/0001104659-26-027690.md) | [4.1](/filings/0001104659-26-057266.md) | [10.2 d](/filings/0001104659-26-092615.md) | [(1.1) d](/filings/0001104659-25-108344.md) | [24.0 d](/filings/0001104659-26-027690.md) | [17.4](/filings/0001104659-26-057266.md) | [7.7 d](/filings/0001104659-26-092615.md) |
| Capital expenditure | $m | [1.2 d](/filings/0001558370-24-015014.md) | [0.7 d](/filings/0001558370-25-002984.md) | [0.2](/filings/0001558370-25-007097.md) | [0.2 d](/filings/0001558370-25-010741.md) | [0.6 d](/filings/0001104659-25-108344.md) | [0.5 d](/filings/0001104659-26-027690.md) | [0.4](/filings/0001104659-26-057266.md) | [0.3 d](/filings/0001104659-26-092615.md) | [0.2 d](/filings/0001104659-25-108344.md) | [0.9 d](/filings/0001104659-26-027690.md) | [0.6](/filings/0001104659-26-057266.md) | [0.9 d](/filings/0001104659-26-092615.md) |
| Dividends paid | $m | [2.4 d](/filings/0001558370-24-015014.md) | [0.0 d](/filings/0001558370-24-003196.md) | [4.7](/filings/0001558370-25-007097.md) | [2.5 d](/filings/0001558370-25-010741.md) | [2.5 d](/filings/0001104659-25-108344.md) | [0.1 d](/filings/0001104659-26-027690.md) | [2.5](/filings/0001104659-26-057266.md) | [2.6 d](/filings/0001104659-26-092615.md) | [2.7 d](/filings/0001104659-25-108344.md) | [0.0 d](/filings/0001104659-26-027690.md) | [23.9](/filings/0001104659-26-057266.md) | [2.6 d](/filings/0001104659-26-092615.md) |
| Share repurchases | $m | [1.3 d](/filings/0001558370-24-015014.md) | [0.9 d](/filings/0001558370-25-002984.md) | [0.0](/filings/0001558370-25-007097.md) | [0.5 d](/filings/0001558370-25-010741.md) | [0.1 d](/filings/0001104659-25-108344.md) | [0.0 d](/filings/0001104659-26-027690.md) | [0.7](/filings/0001104659-26-057266.md) | [2.4 d](/filings/0001104659-26-092615.md) | [0.9 d](/filings/0001104659-25-108344.md) | [1.2 d](/filings/0001104659-26-027690.md) | [0.0](/filings/0001104659-26-057266.md) | [0.0 d](/filings/0001104659-26-092615.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,605](/filings/0001410578-23-002272.md) | [9,545](/filings/0001558370-24-007553.md) | [9,542](/filings/0001558370-24-011519.md) | [9,530](/filings/0001558370-24-015014.md) | [9,580](/filings/0001558370-25-007097.md) | [9,548](/filings/0001558370-25-010741.md) | [9,599](/filings/0001104659-25-108344.md) | [9,664](/filings/0001104659-26-057266.md) | [9,561](/filings/0001104659-26-092615.md) | [9,535](/filings/0001104659-25-108344.md) | [9,509](/filings/0001104659-26-057266.md) | [9,561](/filings/0001104659-26-092615.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,550,983 at 2026-07-27, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092615.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.